ANDYKLA · COMPANIONS · AI · ROBOTICS
EUROPEHUMAN-CENTERED AI

ANDYKLA · COMPANIONS · AI · ROBOTICS

Human-centered AI.
Technology for human life.

ANDYKLA combines artificial intelligence with suitable humanoid hardware. Our focus is social interaction, communication, companionship and practical everyday applications – with ANDYKLA CARE as the first European use case.

Companion AIHumanoid RoboticsCare & Assisted LivingHardware-independent Platform

THE PLATFORM

The intelligence is the product. Hardware is the platform.

ANDYKLA is not setting out to build another humanoid robot from scratch. We are developing the AI, companion and application layer that can connect to suitable robotics platforms.

CORE

ANDYKLA AI

Dialogue, personality, context, user profiles and secure integrations.

CARE

ANDYKLA CARE

Companionship, engagement and assistance for care and assisted-living environments.

INTEGRATION

Robotics Layer

Integration of suitable hardware through SDKs, APIs, ROS 2 and manufacturer interfaces.

BUSINESS

RaaS

Recurring revenue models based on platform, service and robotics usage.

ANDYKLA CARE

Our first real-world application.

The planned pilot focuses on social companionship and supportive functions. Medical decisions or autonomous nursing procedures are not part of the initial pilot.

01 · SELECTEvaluate suitable humanoid hardware
02 · INTEGRATEIntegrate ANDYKLA AI and companion functions
03 · PILOTReal-world deployment with partner facilities
04 · SCALEPrepare commercial RaaS rollouts
Explore CARE

TECHNOLOGY PARTNERS

We are looking for hardware that already exists.

ANDYKLA is evaluating manufacturers with commercially available humanoid hardware, open development interfaces and a perspective for deployment in Europe.

Partnership requirements

What we are looking for

SDK/API · ROS 2 · Python/C++ · external AI/LLM integration · sensor access · teleoperation · autonomous docking · EU conformity · OEM/white label · leasing/RaaS.

INVESTMENT

Capital for integration and scaling – not reinventing the hardware.

The financing structure will be based on real manufacturer quotations, pilot costs and defined milestones. The objective is a model with early commercial revenue and recurring income.

Investor Information

IMMUMEDIC GROUP

Healthcare · AI · Technology

ANDYKLA is being developed within the IMMUMEDIC Group environment. Existing companies and future ANDYKLA structures remain legally transparent and separate; investments are intended to be structured specifically for the relevant project.